IMGN853诱导卵巢癌组合疗法中的自细胞死亡
Anca Chelariu-Raicu1,2,3, Thanh Chung Vu1, Sujanitha Umamaheswaran1,4
1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer research communications
|March 3, 2025
概括
抗体-药物结合物IMGN853触发了卵巢癌细胞的自细胞死亡,改善了生存率. 与托波特干或抗VEGF-A抗体的组合显示出增强的瘤减少,支持进一步的临床发展.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 叶酸受体1 (FOLR1) 在上皮卵巢癌中过度表达.
- 针对FOLR1的抗体可以诱导自细胞死亡,但临床相关性尚不清楚.
- IMGN853 (mirvetuximab soravtansine) 是一种针对FOLR1的抗体药物联合体.
研究的目的:
- 研究IMGN853诱导的自细胞死亡在卵巢癌中的作用.
- 探索IMGN853与用于卵巢癌治疗的现有化疗药物的组合.
主要方法:
- 在卵巢瘤中评估FOLR1表达.
- 接受IMGN853.3治疗的携带来自患者的高度血清性卵巢癌 (HGSC) 的小鼠进行异种移植.
- 评估了自流量,细胞死亡标志物 (LC3B-II,分裂的caspase-3) 和贝克林-1的依赖性.
- 经过测试的IMGN853与托波特干,抗VEGF-A抗体 (B20) 和olaparib的组合.
主要成果:
- FOLR1表达在上皮卵巢癌细胞中占主导地位,包括转移性部位.
- IMGN853治疗改善了HGSC异种移植中的存活率,增强了自流,并诱导了细胞死亡.
- IMGN853增加了LC3B-II和分裂的caspase-3表达,依赖于贝克林-1.
- 与托波特干或抗VEGF-A抗体的IMGN853组合相比,单独使用IMGN853显著减少了瘤生长.
结论:
- IMGN853诱导自细胞死亡,有助于其在卵巢癌中的抗瘤作用.
- 有效的组合疗法包括IMGN853与托波特干或抗VEGF-A抗体.
- 了解FOLR1-介导的自机制可以促进IMGN853的临床发展.
相关概念视频
The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461


